RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Qing Li to Carcinoma, Hepatocellular

This is a "connection" page, showing publications Qing Li has written about Carcinoma, Hepatocellular.
Connection Strength

0.352
  1. Liang G, Tang A, Lin X, Li L, Zhang S, Huang Z, Tang H, Li QQ. Green tea catechins augment the antitumor activity of doxorubicin in an in vivo mouse model for chemoresistant liver cancer. Int J Oncol. 2010 Jul; 37(1):111-23.
    View in: PubMed
    Score: 0.314
  2. Hu B, Huang W, Wang R, Zang W, Su M, Li H, Wang H, Cao B, Deng D, Li QQ, Jiang J. High Rate of Detection of Human ESPL1-HBV S Fusion Gene in Patients With HBV-related Liver Cancer: A Chinese Case-Control Study. Anticancer Res. 2020 Jan; 40(1):245-252.
    View in: PubMed
    Score: 0.038
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support